Effect of Endoscopic Gastroplication on the Genome-Wide Transcriptome in the Upper Gastrointestinal Tract
-
By
-
Nikkie van der Wielen
-
Givan Paulus
-
Mark van Avesaat
-
Ad Masclee
-
Jocelijn Meijerink
-
Nicole Bouvy
-
September 13, 2016
-
Clinical Scorecard: Impact of Endoscopic Gastroplication on Genome-Wide Transcriptomic Changes in the Upper Gastrointestinal Region
At a Glance
| Category | Detail |
|---|
| Condition | Severe obesity with or without comorbidities |
| Key Mechanisms | Reduction of stomach volume via endoscopic gastroplication leading to weight loss and molecular changes in upper GI tract tissues |
| Target Population | Adults aged 18-50 years with BMI 40-45 kg/m2 or BMI 30-39.9 kg/m2 with obesity-related comorbidities |
| Care Setting | Specialized bariatric/endoscopy centers performing minimally invasive transoral procedures |
Key Highlights
- Endoscopic gastroplication using the ACE stapler reduces stomach volume without tissue removal or intestinal bypass.
- Median excess weight loss of 34.9% observed at one year post-procedure with only mild adverse effects reported.
- Transcriptomic analysis of stomach and duodenal biopsies reveals molecular changes potentially underlying metabolic and anti-inflammatory effects.
Guideline-Based Recommendations
Diagnosis
- Assess eligibility based on BMI criteria and presence of obesity-related comorbidities.
- Perform baseline upper GI endoscopy with mucosal biopsies for molecular analysis if indicated.
Management
- Perform endoscopic gastroplication via transoral ACE stapler to reduce stomach volume by creating multiple plications.
- Encourage adherence to a healthy lifestyle post-procedure with regular outpatient follow-up.
Monitoring & Follow-up
- Schedule follow-up endoscopy with repeat biopsies at 12 months to assess transcriptomic changes.
- Monitor weight loss outcomes and metabolic parameters including HbA1c and plasma biomarkers.
- Evaluate for adverse effects and patient adherence to lifestyle modifications.
Risks
- Mild adverse effects reported; procedure avoids skin incisions and intestinal bypass, potentially reducing complication risks.
Patient & Prescribing Data
Adults with severe obesity eligible for minimally invasive bariatric intervention
Endoscopic gastroplication achieves significant weight loss and induces molecular changes in upper GI mucosa associated with metabolic improvements.
Clinical Best Practices
- Select patients carefully based on BMI and comorbidity profile consistent with study inclusion criteria.
- Use standardized protocols for biopsy collection and molecular analysis to monitor biological effects.
- Combine procedural intervention with lifestyle counseling to optimize long-term outcomes.
References
